Herz, A., Guberina, M., Pöttgen, C., Gauler, T., Ton, M., Fischedick, G., . . . Guberina, N. (2025). The effect of durvalumab consolidation after definitive radiochemotherapy for non-operable stage III non-small cell lung cancer on the dose effect relation for therapy related pulmonary infiltrates as a risk factor for pneumonitis. Translational Lung Cancer Research, 14(6), . https://doi.org/10.21037/tlcr-2024-1284
Chicago Style (17th ed.) CitationHerz, Andreas, et al. "The Effect of Durvalumab Consolidation After Definitive Radiochemotherapy for Non-operable Stage III Non-small Cell Lung Cancer on the Dose Effect Relation for Therapy Related Pulmonary Infiltrates as a Risk Factor for Pneumonitis." Translational Lung Cancer Research 14, no. 6 (2025). https://doi.org/10.21037/tlcr-2024-1284.
MLA (9th ed.) CitationHerz, Andreas, et al. "The Effect of Durvalumab Consolidation After Definitive Radiochemotherapy for Non-operable Stage III Non-small Cell Lung Cancer on the Dose Effect Relation for Therapy Related Pulmonary Infiltrates as a Risk Factor for Pneumonitis." Translational Lung Cancer Research, vol. 14, no. 6, 2025, https://doi.org/10.21037/tlcr-2024-1284.